Healthcare
1933 Industries Inc.(TGIFF)
Live Price
Offline$0.0057
+14.00% today
1Y Change
+20.48%
Window
Jun 20, 2025 โ Jun 17, 2026
- Market Cap
- $10.00M
- Revenue Growth
- -34.9%
- EPS Growth
- +100.0%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 20, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
1933 Industries Inc. (TGIFF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.01 and up 20.5% across the available one-year price window (Jun 20, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -34.9%, EPS growth of +100.0%, a dividend yield of 0.0%. What stands out right now is revenue -34.9%, EPS +100.0%, free cash flow +50.1% with operating margin -6.4% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at P/E 16.1 and price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TGIFF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-34.9% vs +7.6% peer median
Operating Margin
Below sector median
-6.4% vs +19.4% peer median
P/E
Below sector median
16.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 7, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -34.9% and EPS is at +100.0%, with operating margin around -6.4%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 1, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +12.8% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 7, 2026 | โ | +20.0% | +30.0% | +46.0% |
2026 Mar 30, 2026 | +106.8% | +0.0% | +0.0% | +66.0% |
2025 Jul 31, 2025 | โ | +14.5% | +8.3% | +23.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TGIFF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TGIFF Max Drawdown
-70.71%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TGIFF and SPY.
Company Overview
1933 Industries Inc.
Other OTC
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in the medical and recreational cannabis sectors. The company also offers cannabidiol (CBD) infused products, such as vape pens, cartridges, lotions, lip balms, hemp seed oils, edible products, topical and dietary supplements, cosmetics, tinctures, sauces, vaporizers, drink additives, baking items, sweeteners, capsules, and tetrahydrocannabinol concentrates under the Canna Hemp, Canna Hemp X, Canna Hemp PLUS, Canna Hemp HEMP, and Canna Fused brands. In addition, it provides cannabis flowers and concentrates. 1933 Industries Inc. offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
- Leadership
- Brian Farrell
- IPO Date
- May 22, 2013
- Employees
- 85
- Street Address
- 1055 West Hastings Street
- Mailing
- Vancouver, BC, V6E 2E9
- Region
- Vancouver, BC, CA
- Reporting Currency
- USD
- Investor Line
- 604-728-4407
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 16.1
- EV/EBITDA
- โ
- Price/Sales
- 0.5
- Price/Book
- โ
Growth
- Revenue
- -34.9%
- EPS
- +100.0%
- Free Cash Flow
- +50.1%
Profitability
- Gross Margin
- 13.6%
- Operating Margin
- -6.4%
- Net Margin
- 2.8%
- ROE
- -11.1%
- ROIC
- -7.8%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.